2015 Q4 Form 10-Q Financial Statement

#000119312515368169 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $338.4M $326.5M $300.5M
YoY Change 12.61% 8.72% -0.56%
Cost Of Revenue $192.5M $186.8M $171.4M
YoY Change 12.31% 9.76% -3.92%
Gross Profit $145.9M $139.7M $129.2M
YoY Change 12.93% 7.38% 4.36%
Gross Profit Margin 43.11% 42.79% 43.0%
Selling, General & Admin $125.0M $116.2M $107.2M
YoY Change 16.6% 8.19% -10.37%
% of Gross Profit 85.68% 83.18% 82.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.200M $4.600M $6.200M
YoY Change -32.26% -29.23% -28.74%
% of Gross Profit 2.88% 3.29% 4.8%
Operating Expenses $129.2M $120.8M $113.4M
YoY Change 13.93% 6.15% -8.84%
Operating Profit $16.70M $16.72M $15.80M
YoY Change 5.7% 2.87% -2733.33%
Interest Expense $200.0K $4.936M -$1.800M
YoY Change -111.11% 65.08% 28.57%
% of Operating Profit 1.2% 29.53% -11.39%
Other Income/Expense, Net $5.800M -$1.675M $1.500M
YoY Change 286.67% -26.95% -250.0%
Pretax Income $22.60M $15.04M $14.50M
YoY Change 55.86% 7.77% -201.4%
Income Tax $9.600M $6.465M $5.200M
% Of Pretax Income 42.48% 42.99% 35.86%
Net Earnings $12.90M $8.400M $9.100M
YoY Change 41.76% 0.0% -194.79%
Net Earnings / Revenue 3.81% 2.57% 3.03%
Basic Earnings Per Share $0.39 $0.25 $0.28
Diluted Earnings Per Share $0.38 $0.25 $0.28
COMMON SHARES
Basic Shares Outstanding 33.69M shares 33.13M shares
Diluted Shares Outstanding 33.63M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.50M $57.10M $8.000M
YoY Change 243.75% 938.18% -53.76%
Cash & Equivalents $27.50M $57.05M $8.032M
Short-Term Investments
Other Short-Term Assets $22.70M $5.641M $19.71M
YoY Change 15.18% -83.41% 82.74%
Inventory
Prepaid Expenses $8.493M
Receivables $125.0M $121.7M $99.33M
Other Receivables $0.00 $0.00 $15.00M
Total Short-Term Assets $175.3M $216.4M $135.6M
YoY Change 29.32% 52.0% -33.96%
LONG-TERM ASSETS
Property, Plant & Equipment $42.70M $41.49M $137.5M
YoY Change -68.94% -70.67% -13.56%
Goodwill $261.7M $211.1M $205.6M
YoY Change 27.29% -1.58%
Intangibles $44.00M $33.15M $33.20M
YoY Change 32.53% -9.54%
Long-Term Investments $29.70M
YoY Change 28.02%
Other Assets $158.0M $164.3M $33.16M
YoY Change 376.46% 3.53% 26.17%
Total Long-Term Assets $506.4M $450.0M $534.2M
YoY Change -5.2% -16.64% 2.51%
TOTAL ASSETS
Total Short-Term Assets $175.3M $216.4M $135.6M
Total Long-Term Assets $506.4M $450.0M $534.2M
Total Assets $681.7M $666.4M $669.7M
YoY Change 1.79% -2.32% -7.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.68M $24.23M $16.06M
YoY Change 59.95% 25.11% -20.27%
Accrued Expenses $71.97M $69.19M $56.33M
YoY Change 27.76% -56.68% -2.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $3.800M $12.00M
YoY Change -58.33% -68.33% -13.67%
Total Short-Term Liabilities $175.2M $171.2M $162.3M
YoY Change 7.93% -10.39% -48.04%
LONG-TERM LIABILITIES
Long-Term Debt $91.60M $96.30M $104.4M
YoY Change -12.26% -5.87% 216.36%
Other Long-Term Liabilities $4.500M $4.998M $5.285M
YoY Change -14.85% -13.05% -37.9%
Total Long-Term Liabilities $91.60M $101.3M $109.7M
YoY Change -16.49% -6.25% 164.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $175.2M $171.2M $162.3M
Total Long-Term Liabilities $91.60M $101.3M $109.7M
Total Liabilities $274.6M $272.5M $272.0M
YoY Change 0.98% -8.91% -23.15%
SHAREHOLDERS EQUITY
Retained Earnings -$67.81M -$64.79M
YoY Change 4.66% -16.47%
Common Stock $504.3M $495.8M $481.8M
YoY Change 4.68% 2.96%
Preferred Stock
YoY Change
Treasury Stock (at cost) $26.97M $22.03M $19.86M
YoY Change 35.78% 9.26%
Treasury Stock Shares 1.180M shares 1.054M shares 975.0K shares
Shareholders Equity $409.6M $393.1M $397.2M
YoY Change
Total Liabilities & Shareholders Equity $681.7M $666.4M $669.7M
YoY Change 1.79% -2.31% -7.8%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income $12.90M $8.400M $9.100M
YoY Change 41.76% 0.0% -194.79%
Depreciation, Depletion And Amortization $4.200M $4.600M $6.200M
YoY Change -32.26% -29.23% -28.74%
Cash From Operating Activities $20.10M $30.70M $4.600M
YoY Change 336.96% 20.87% -45.24%
INVESTING ACTIVITIES
Capital Expenditures -$3.400M -$1.300M -$2.100M
YoY Change 61.9% 62.5% -83.46%
Acquisitions
YoY Change
Other Investing Activities -$44.10M -$6.700M -$3.000M
YoY Change 1370.0% -770.0% -266.67%
Cash From Investing Activities -$47.50M -$8.100M -$5.100M
YoY Change 831.37% -4150.0% -53.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.000M 1.100M 3.100M
YoY Change -164.52% -103.51% -113.08%
NET CHANGE
Cash From Operating Activities 20.10M 30.70M 4.600M
Cash From Investing Activities -47.50M -8.100M -5.100M
Cash From Financing Activities -2.000M 1.100M 3.100M
Net Change In Cash -29.40M 23.70M 2.600M
YoY Change -1230.77% -515.79% -109.89%
FREE CASH FLOW
Cash From Operating Activities $20.10M $30.70M $4.600M
Capital Expenditures -$3.400M -$1.300M -$2.100M
Free Cash Flow $23.50M $32.00M $6.700M
YoY Change 250.75% 22.14% -68.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
162323000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5285000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4998000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
171214000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
74050000
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
dei Trading Symbol
TradingSymbol
AMED
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
129992000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33691200 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0
CY2014Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2015Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
326450000
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
300281000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
942174000
CY2015Q3 us-gaap Cost Of Services
CostOfServices
186772000
CY2014Q3 us-gaap Cost Of Services
CostOfServices
170159000
CY2015Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
69993000
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
69461000
us-gaap Share Based Compensation
ShareBasedCompensation
3197000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
114734000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
110240000
CY2014Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4183000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
13318000
CY2015Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
4646000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
15798000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
77268000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2208000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
309735000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
284033000
us-gaap Costs And Expenses
CostsAndExpenses
968036000
us-gaap Costs And Expenses
CostsAndExpenses
894790000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16715000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16248000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25862000
us-gaap Operating Income Loss
OperatingIncomeLoss
9236000
CY2015Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
7000
CY2014Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
24000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
33000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
46000
CY2015Q3 us-gaap Interest Expense
InterestExpense
4936000
CY2014Q3 us-gaap Interest Expense
InterestExpense
2990000
us-gaap Interest Expense
InterestExpense
9778000
us-gaap Interest Expense
InterestExpense
5603000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1924000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
563000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8701000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2234000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1330000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
544000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1675000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2293000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2918000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2779000
CY2015Q3 us-gaap Minority Interest
MinorityInterest
843000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24226000
CY2014Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1053991 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34569526 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33594572 shares
us-gaap Share Based Compensation
ShareBasedCompensation
7637000
CY2014Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
6515000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
9370000
CY2014Q4 us-gaap Assets
Assets
669742000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
135558000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41485000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8032000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16056000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33150000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8493000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19708000
CY2015Q3 us-gaap Goodwill
Goodwill
211109000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75553000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137455000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
216441000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
121744000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56329000
CY2014Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
12000000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33193000
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5641000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99325000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57051000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69188000
CY2015Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2015Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
669742000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397762000
CY2014Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
19860000
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
2385000
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
974954 shares
CY2015Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0
CY2015Q3 us-gaap Liabilities
Liabilities
272462000
CY2015Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3750000
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
495827000
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
22029000
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
393131000
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
393974000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
666436000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
595000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64785000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
397167000
CY2015Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2075000
CY2014Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146438000
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25379000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14753000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14317000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25374000
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
140363000
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34726207 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33672216 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
us-gaap Cost Of Services
CostOfServices
533432000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
224032000
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3060000
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1697000
CY2014Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
32018000
CY2015Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19650000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
904026000
us-gaap Cost Of Services
CostOfServices
519686000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3962000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
209797000
CY2015Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
3638000
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8439000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
117000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
22109000
us-gaap Interest Paid
InterestPaid
5598000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-12383000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1554000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
668000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4081000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9882000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70129000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67530000
CY2014Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.81 pure
CY2014Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
18800000
CY2015Q3 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20 pure
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15040000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13955000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22944000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6457000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6465000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7560000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2483000
CY2015Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
8575000
CY2014Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
8597000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-15384000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3974000
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2015Q3 us-gaap Profit Loss
ProfitLoss
8575000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
8597000
us-gaap Profit Loss
ProfitLoss
-15384000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
135000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
158000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
548000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
8440000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
8439000
us-gaap Net Income Loss
NetIncomeLoss
-15932000
us-gaap Net Income Loss
NetIncomeLoss
3641000
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.26
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.48
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.12
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.26
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.48
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.12
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-15932000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-216000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3857000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-945000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9547000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5848000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17303000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13392000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9370000
us-gaap Pension Expense
PensionExpense
4544000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
184000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-286000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
413000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
63400000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
200800000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
4233000
us-gaap Pension Expense
PensionExpense
4682000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2762000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2967000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
190800000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
2561000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
3421000
amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
-115000000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
0
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
300000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
78400000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
5000000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
0
amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
-1549000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
49019000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87741000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1077000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12701000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
803000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8597000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
774000
CY2015Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.79 pure
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5135000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31788000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9152000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
67371000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15798000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22149000
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
2513000
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
488000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5800000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17969000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
19000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19859000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
399000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1591000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18863000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9162000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
521000
us-gaap Interest Paid
InterestPaid
4771000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6357000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
104000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4174000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
89000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
9000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1885000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1875000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2553000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10904000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
103000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11761000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5542000
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates</font></p><p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and </font><font style="font-family:Times New Roman;font-size:10pt;">reporting policies conform with </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></p>
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
466000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
496000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
107000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
89000 shares
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
901000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
116400000
CY2015Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
24400000
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.80 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10 pure
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2015Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
CY2015Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50 pure
CY2015Q3 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2015Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 States
CY2015Q3 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.50 pure
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2014Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.96 pure
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
CY2014 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.69 pure
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2015Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1500000
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.65 pure
CY2014Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1400000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
4000000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
4100000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32957000 shares
CY2015Q3 us-gaap Land
Land
0
CY2014Q4 us-gaap Land
Land
3200000
CY2014Q4 amed Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
25300000
CY2014Q4 amed Equipmentandfurniture
Equipmentandfurniture
97200000
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
158200000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
283900000
CY2015Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
91900000
CY2015Q3 amed Equipmentandfurniture
Equipmentandfurniture
87900000
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
181900000
CY2015Q3 amed Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
2100000
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
57000 shares
CY2015Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
446000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
983000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33631000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33128000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32468000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32934000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32957000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32690000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32194000 shares
CY2015Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3600000
CY2015Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2015Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2015Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2014Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2014Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2014Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
332100000
CY2015Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
112600000
CY2014Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
103200000
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
100000000
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
96300000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
104400000
CY2015Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000
us-gaap Debt Issuance Costs
DebtIssuanceCosts
2400000
CY2015Q3 amed Total Leverage Ratio
TotalLeverageRatio
1.0 pure
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2500000
CY2015Q3 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
3.2 pure
CY2015Q3 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
337500000
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000

Files In Submission

Name View Source Status
0001193125-15-368169-index-headers.html Edgar Link pending
0001193125-15-368169-index.html Edgar Link pending
0001193125-15-368169.txt Edgar Link pending
0001193125-15-368169-xbrl.zip Edgar Link pending
amed-20150930.xml Edgar Link completed
amed-20150930.xsd Edgar Link pending
amed-20150930_cal.xml Edgar Link unprocessable
amed-20150930_def.xml Edgar Link unprocessable
amed-20150930_lab.xml Edgar Link unprocessable
amed-20150930_pre.xml Edgar Link unprocessable
d10612d10q.htm Edgar Link pending
d10612dex311.htm Edgar Link pending
d10612dex312.htm Edgar Link pending
d10612dex321.htm Edgar Link pending
d10612dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g10612fs_pg001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending